Cisplatinum and docetaxel for ovarian cancer in pregnancy

[1]  O. Mir,et al.  Use of platinum derivatives during pregnancy , 2008, Cancer.

[2]  F. Amant,et al.  Gynecologic oncology in pregnancy. , 2008, Critical reviews in oncology/hematology.

[3]  J. H. Kim,et al.  Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy. , 2008, Lung cancer.

[4]  N. Sagawa,et al.  Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature. , 2008, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[5]  F. Machado,et al.  Ovarian cancer during pregnancy: analysis of 15 cases. , 2007, Gynecologic oncology.

[6]  F. Nezhat,et al.  Induction of ovulation and ovarian cancer: a critical review of the literature. , 2006, Fertility and sterility.

[7]  J. Thigpen.  Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-Line Chemotherapy for Ovarian Carcinoma , 2006 .

[8]  N. Pavlidis,et al.  Cancer and pregnancy: poena magna, not anymore. , 2006, European journal of cancer.

[9]  J. Lang,et al.  Ovarian cancer in pregnancy: a clinicopathologic analysis of 22 cases and review of the literature , 2005, International Journal of Gynecologic Cancer.

[10]  Alan Gordon,et al.  Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. , 2004, Journal of the National Cancer Institute.

[11]  E. Attar,et al.  Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: case report. , 2004, Human reproduction.

[12]  A. Venn,et al.  Risk of cancer after use of fertility drugs with in-vitro fertilisation , 1999, The Lancet.